The effect of Preotact on the healing of fracture of the upper arm bone.

• Conditions: Fracture of proximal humerus; MedDRA version: 14.1Level: PTClassification code 10020462Term: Humerus fractureSystem Organ Class: 10022117 - Injury, poisoning and procedural complications; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: EUCTR2011-005801-54-DK
• Lead Sponsor: Hvidovre Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02-14
• Last Update Posted: 14 September 2015

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Age 65-85
Fracture of the proximal humerus assessed with X-ray that can be treated conservatively.
Understand the protocol and what participation involves.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 60

Exclusion Criteria

Metabolic bone disease
A history with malignant diesase except baso-cellular carcinoma.
History with x-ray therapy of the sceleton.
Treatment with orally administered antiresorptive medication within the last 3 months.
Treatment with intravenously administered bisphosphonates within the last 12 months.
Treatment with denusomab within the last 6 months.
Pathological fracture.
Glumerular filtration rate < 30 mL/min.
Liver insufficiency.
Ionozed calcium > 1.40 mmol/l
Pregnancy
Allergy to study medication

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified